Jelena Lazic

1. RONCERAY, Leila, ABLA, Oussama, BARZILAI-BIRENBOIM, Shlomit, BOMKEN, Simon, CHIANG, Alan K.S., JAZBEC, Janez, KABICKOVA, Edita, LAZIC, Jelena, BEISHUIZEN, Auke, MELLGREN, Karin, et al. Children and adolescents with marginal zone lymphoma have an excellent prognosis with limited chemotherapy or a watch-and-wait strategy after complete resection. Pediatric blood & cancer. Apr. 2018, vol. 65, iss. 4, str. 1-6. ISSN 1545-5017. https://onlinelibrary.wiley.com/doi/10.1002/pbc.26932, DOI: 10.1002/pbc.26932. [COBISS.SI-ID 4563372]

2. GASIC, Vladimir, ZUKIC, Branka, STANKOVIĆ, Biljana, JANIĆ, Dragana, DOKMANOVIC, Lidija, LAZIC, Jelena, KRSTOVSKI, Nada, DOLŽAN, Vita, JAZBEC, Janez, PAVLOVIČ, Sonja, KOTUR, Nikola. Pharmacogenomic markers of glucorticoid responses in the initial phase of remission induction therapy in childhood acute lymphoblastic leukemia. Radiology and oncology. [Print ed.]. 2018, vol. 52, no. 3, str. 296-306, v, tabele. ISSN 1318-2099. DiRROS - Digitalni repozitorij raziskovalnih organizacij Slovenije, Digitalna knjižnica Slovenije - dLib.si, DOI: 10.2478/raon-2018-0034. [COBISS.SI-ID 5314476]

3. STANKOVIĆ, Mia, KLJUN, Jakob, STEVANOVIĆ, Nevena Lj., LAZIC, Jelena, SKARO-BOGOJEVIC, Sanja, VOJNOVIĆ, Sandra, ZLATAR, Matija, NIKODINOVIĆ-RUNIĆ, Jasmina, TUREL, Iztok, DJURAN, Miloš I., GLIŠIĆ, Biljana. Silver(I) complexes containing antifungal azoles : significant improvement of the anti-Candida potential of the azole drug after its coordination to the silver(I) ion. Dalton transactions. [Spletna izd.]. 7 Feb. 2024, vol. 53, iss. 5, str. 2218-2230, ilustr. ISSN 1477-9234. https://pubs.rsc.org/en/content/articlelanding/2024/dt/d3dt03010e, DOI: 10.1039/D3DT03010E. [COBISS.SI-ID 183209987]